Get started
AAREY DRUGS & PHARMACEUTICALSAAREY DRUGS & PHARMACEUTICALSAAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

AAREYDRUGS chart


Full chart

AAREYDRUGS upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.84 B‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
29.03
Basic EPS (TTM)
2.27 INR
Net income (FY)
‪46.84 M‬ INR
Revenue (FY)
‪3.95 B‬ INR
Shares float
—
Beta (1Y)
1.09

About AAREY DRUGS & PHARM LTD


Sector
Health Technology
CEO
Mihir Rajesh Ghatalia
Headquarters
Mumbai
Website
aareydrugs.com
Founded
1990
ISIN
INE198H01019
FIGI
BBG000D2FHM2
Aarey Drugs & Pharmaceuticals Ltd. engages in the trade and manufacture of pharmaceutical ingredients, drug intermediates, specialty chemicals, industrial solvents, and chemicals. Its products include mono methyl urea, dimethyl urea, theobromine, theophylline, mefanamic acid, bromomethyl, and dioxolane. The company was founded by Rajesh Pranlal Ghatalia on May 15, 1990 and is headquartered in Mumbai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

AAREYDRUGS news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of AAREYDRUGS is 63.51 INR — it has decreased by −3.61% in the past 24 hours. Watch AAREY DRUGS & PHARMACEUTICALS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange AAREY DRUGS & PHARMACEUTICALS stocks are traded under the ticker AAREYDRUGS.
AAREYDRUGS stock has fallen by −1.52% compared to the previous week, the month change is a 0.83% rise, over the last year AAREY DRUGS & PHARMACEUTICALS has showed a −6.41% decrease.
AAREYDRUGS reached its all-time high on Sep 5, 2024 with the price of 75.75 INR, and its all-time low was 37.00 INR and was reached on Mar 18, 2024. View more price dynamics on AAREYDRUGS chart.
See other stocks reaching their highest and lowest prices.
AAREYDRUGS stock is 5.26% volatile and has beta coefficient of 1.09. Track AAREY DRUGS & PHARMACEUTICALS stock price on the chart and check out the list of the most volatile stocks — is AAREY DRUGS & PHARMACEUTICALS there?
Today AAREY DRUGS & PHARMACEUTICALS has the market capitalization of ‪1.84 B‬, it has decreased by −1.02% over the last week.
Yes, you can track AAREY DRUGS & PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
AAREY DRUGS & PHARMACEUTICALS is going to release the next earnings report on Nov 11, 2024. Keep track of upcoming events with our Earnings Calendar.
AAREYDRUGS net income for the last quarter is ‪12.39 M‬ INR, while the quarter before that showed ‪21.52 M‬ INR of net income which accounts for −42.42% change. Track more AAREY DRUGS & PHARMACEUTICALS financial stats to get the full picture.
AAREY DRUGS & PHARMACEUTICALS dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AAREY DRUGS & PHARMACEUTICALS EBITDA is ‪42.91 M‬ INR, and current EBITDA margin is 2.41%. See more stats in AAREY DRUGS & PHARMACEUTICALS financial statements.
Like other stocks, AAREYDRUGS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AAREY DRUGS & PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AAREY DRUGS & PHARMACEUTICALS technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AAREY DRUGS & PHARMACEUTICALS stock shows the buy signal. See more of AAREY DRUGS & PHARMACEUTICALS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.